Indiana’s life sciences industry delivers a $55 billion economic impact to the state. Compared to other states and regions, we have a significant competitive advantage because of our focus on cultivating a skilled workforce, engaged university and academic institutions, strong philanthropic support, novel public-private partnerships, access to capital and a positive business climate.
Indiana is home to nearly 2,000 companies and more than 55,000 life sciences workers at places like the global headquarters for Biomet, Cook Medical, DePuy Orthopaedics, Dow AgroSciences, Eli Lilly and Company, WellPoint, and Zimmer and the North American headquarters of Roche Diagnostics; Beckman Coulter, Boston Scientific, Covance, and Mead Johnson have major operations located within the state.
In addition, we have a vibrant start up environment and many promising companies both from universities and entrepreneurs have been established over the last several years. We have a diverse and robust industry from pharmaceuticals to medical devices to agricultural biotech, laboratories, and health information technology enterprises.
The mission of BioCrossroads is to serve as a catalyst for the continued growth of Indiana's robust life sciences industry. By doing so, we will create an environment that provides more economic opportunity and a thriving entrepreneurial network as well as better healthcare for our communities and inspiration for young talent.
BioCrossroads is a catalyst for life sciences ideas. Whether it’s providing funding, launching new initiatives like the Indiana Biosciences Research Institute, or partnering with our state’s research institutions, global companies, philanthropic organizations and government, BioCrossroads is advancing Indiana’s next generation of growth and innovation. We make connections for Indiana’s life sciences companies and work to accelerate their success.